Biological Therapy Analysis & Statistics, July 2014 (p3)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

All regions

You might be interested in: stem cell, tissue engineering, cell therapy, more »

61-90 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Cellartis AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cellartis AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Cellartis AB (Cellartis) is a biotechnology company. The company provides pluripotent stem cells and human embryonic stem cells, and technology for drug discovery research, toxicity testing and ...

  • Industries : Biological Therapy
  • Countries : United States
MaxCyte, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

MaxCyte, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary MaxCyte, Inc. (MaxCyte) is a biotherapeutics company. The company offers cell-based therapies for chronic and acute diseases. It offers products such as MaxCyte STX, MaxCyte VLX and MaxCyte GT. ...

  • Industries : Biological Therapy
  • Countries : United States
Lentigen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Lentigen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Lentigen Corporation (Lentigen) is a biotechnology company. The company develops and commercializes lentiviral vector technology for a range of therapeutic, vaccine, and bioproduction applications. ...

  • Industries : Biological Therapy
  • Countries : United States
Bioheart, Incorporation

Bioheart, Incorporation

  • $ 55
  • Company report
  • October 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Bioheart, Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Biological Therapy
Shanghai Jiaoda Onlly Co., Ltd.

Shanghai Jiaoda Onlly Co., Ltd.

  • $ 55
  • Company report
  • October 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Shanghai Jiaoda Onlly Co., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy
Peptidream Inc

Peptidream Inc

  • $ 55
  • Company report
  • October 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Peptidream Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biological Therapy
  • Countries : Japan
3-D Matrix Ltd

3-D Matrix Ltd

  • $ 55
  • Company report
  • October 2014
  • by Wright Investors' Service

A textual analysis of the financial results for 3-D Matrix Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biological Therapy
  • Countries : Japan
International Stem Cell Corporation

International Stem Cell Corporation

  • $ 55
  • Company report
  • October 2014
  • by Wright Investors' Service

A textual analysis of the financial results for International Stem Cell Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy
Japan Tissue Engineering Company Limited

Japan Tissue Engineering Company Limited

  • $ 55
  • Company report
  • October 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Japan Tissue Engineering Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Biological Therapy
  • Countries : Japan
Zhongyuan Union Stem Cell Bio-Engineering Corp

Zhongyuan Union Stem Cell Bio-Engineering Corp

  • $ 55
  • Company report
  • September 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Zhongyuan Union Stem Cell Bio-Engineering Corp compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Biological Therapy
Tissue Therapies Ltd

Tissue Therapies Ltd

  • $ 55
  • Company report
  • September 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Tissue Therapies Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biological Therapy
Chiome Bioscience Inc

Chiome Bioscience Inc

  • $ 55
  • Company report
  • September 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Chiome Bioscience Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biological Therapy
  • Countries : Japan
Sunzen Biotech Bhd

Sunzen Biotech Bhd

  • $ 55
  • Company report
  • August 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Sunzen Biotech Bhd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biological Therapy
  • Countries : Japan
GENova Biotherapeutics, Inc. (GVBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GENova Biotherapeutics, Inc. (GVBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary GENova Biotherapeutics, Inc. (GENova) is a publicly traded biotechnological drug development company, engaged in the identifying, evaluating and acquiring drugs for treatment of oncological and ...

  • Industries : Biological Therapy
  • Countries : United States
Mesoblast Limited (MSB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mesoblast Limited (MSB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Mesoblast Limited (Mesoblast) is a biotechnology company. It focuses on developing novel biotherapeutics using its cell-based technologies for the treatment of a wide range of diseases. The company's ...

  • Industries : Biological Therapy
Japan Tissue Engineering Co., Ltd. (7774) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Japan Tissue Engineering Co., Ltd. (7774) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Japan Tissue Engineering Co., Ltd. (J-TEC) is a biotechnology company. The company develops, manufactures and sells tissue-engineered medical products and related products. Its products include ...

  • Industries : Biological Therapy
  • Countries : Japan
International Stem Cell Corporation (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

International Stem Cell Corporation (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company. The company develops parthenogenesis, a stem cell technology that advances the field of regenerative medicine. It develops ...

  • Industries : Biological Therapy
  • Countries : India, United States
Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments ...

  • Industries : Biological Therapy
Pharmicell Co., Ltd. (005690) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmicell Co., Ltd. (005690) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Pharmicell Co., Ltd. (Pharmicell) is a biotechnology company. The company develops and commercializes stem cell therapeutics for incurable diseases such as cancer, brain and nervous system disorde ...

  • Industries : Biological Therapy
Immunotherapy in Oncology Drug Pipeline Update 2014

Immunotherapy in Oncology Drug Pipeline Update 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...

  • Industries : Biological Therapy
Gene Therapy in Oncology Drug Pipeline Update 2014

Gene Therapy in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

There are today 120 companies plus partners developing 107 gene therapy drugs in 276 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs ...

  • Industries : Biological Therapy
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 332 companies plus partners developing 441 Androgen Receptor drugs in 1457 developmental projects in cancer. ...

  • Industries : Biological Therapy
B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-recepto ...

  • Industries : Biological Therapy
EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014

EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The EGFR1 signaling pathway activates the Ras/Raf/MAPK signaling modules. There are today 371 companies plus partners developing 642 EGFR1 pathway targeting drugs in 2397 developmental projects in cancer. ...

  • Industries : Biological Therapy
Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2014

Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Aberrant activation of the Hedgehog pathway has been associated with a number of human malignancies including carcinoma of lung, esophagus, pancreas and prostate. There are today 119 companies plus partners ...

  • Industries : Biological Therapy
ID Signaling Pathway in Oncology Drug Pipeline Update 2014

ID Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 749
  • Industry report
  • July 2014
  • by Bioseeker

Inhibitor of DNA binding (ID) proteins are members of the helix-loop-helix (HLH) family of proteins which lack a DNA binding domain themselves but bind to other family members inhibiting their DNA binding ...

  • Industries : Biological Therapy
Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Aberrant Notch signaling has been linked to a number of malignancies including leukemias, lymphomas and carcinomas of the breast, skin, lung, cervix and kidneys. There are today 252 companies plus partners ...

  • Industries : Biological Therapy
T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Stimulation of the T cell receptor leads to the activation of NFkB and NFAT signaling modules which play a key role in T cell receptor signaling. There are today 246 companies plus partners developing ...

  • Industries : Biological Therapy
TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The TGF-beta receptor signaling pathway activates the MAPK/SMAD signaling modules. There are today 287 companies plus partners developing 411 TGF-beta receptor pathway targeting drugs in 1411 developmental ...

  • Industries : Biological Therapy
TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2014

TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The TNF-alfa signaling pathway stimulates the MAPK signaling module and activates NFkB. There are today 366 companies plus partners developing 550 TNF-alpha pathway targeting drugs in 2048 developmental ...

  • Industries : Biological Therapy
About 700 reports

Download Unlimited Documents from Trusted Public Sources

Opexa - Investor Report, October 2014

  • Opexa Therapeutics, Inc.
  • October 2014
    37 pages
  • Biological Ther...  

    Drug Discovery ...  

  • World  

View report >

Ethanol Supply In The Us

September 2014

33 Companies

Read our Company Profiles

StemCells Inc.

United States

Bioheart Inc.

United States

Aastrom Biosciences Inc.

United States

Osiris Therapeutics Inc.

United States

Geron Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.